学会発表・講義（国際）
2020年
American Urological Association(AUA2020)
May 15-18, 2020(virtual)
Motion analysis to promote understanding of laparoscopic surgery-dexterity and objective assessment-based simulation training.
Abe T, Ebina K, Higuchi M, Furumido J, Iwahara N, Kon M, Hotta K, Komizunai S, Kurashima Y, Kikuchi H, Matsumoto R, Osawa T, Murai S, Konno A, Shinohara N
Endoscopic Injection Therapy for Vesicoureteral Reflux After Kidney Transplantation.
Higuchi H, Sasaki H, Tanabe T, Hirata Y, Nishimura Y, Minami K, Moriya K, Tanaka H, Harada H
The effectiveness of template-based regional lymph node dissection in reducing locoregional recurrence in patients with clinically node-negative upper urinary tract urothelial carcinoma.
Ryuji Matsumoto, Takashige Abe, Noritaka Takada, Keita Minami, Toru Harabayashi, Satoru Maruyama, Hiroshi Kikuchi, Takahiro Osawa, Nobuo Shinohara
American Transplant Congress(ATC2020)
May 30 - Jun 01(Virtual)
Enough initial tacrolimus blood concentration is crucial even with additional Everolimus in corticosteroid early withdrawal regimen for kidney transplant recipients.
Sasaki H, Tanabe T, Higuchi H, Tsujimoto T, Harada H
The requirement of thymic irradiation for induction of mixed chimerism and renal allograft tolerance
Hirose T, Sasaki H , Oura T, Ma D, Dehnadi A, Colvin RB, Rosales A, Cosimi AB, Kawai T
The 21st International Vascular Biology Meeting(IVBM2020)
September9-12,2020(Seoul, Korea)
Increased ABCB1 expression in tumor blood vessels of urothelial carcinoma after chemotherapy and chemoresistance.
Kikuchi H, Maishi N, Dorcas A. Annan, Mohammad T. Alam, Matsumoto R, Osawa T, Abe T, Hida Y, Harabayashi T, Ameda K, Kashiwagi A, Matsuno Y, Shinohara N, Hida K
The Transplantation Society (TTS2020)
September 12-16(Virtual)
The requirement of thymic irradiation for induction of mixed chimerism and renal allograft tolerance
Hirose T, Sasaki H , Oura T, Ma D, Dehnadi A, Colvin RB, Rosales A, Cosimi AB, Kawai T
The New Era of I-O drug combination treatment -WHAT WOULD YOU DO FIRST?-
October(Sapporo, Japan)
How can we select first line treatment in metastatic RCC?.
篠原信雄